Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1410 results
Astellas, UMN seek marketing approval for Flublok influenza vaccine in Japan
Astellas Pharma and UMN Pharma have announced that Astellas has submitted an application for marketing approval of recombinant influenza HA vaccine ASP7374 to the Ministry of Health, Labour and Welfare in Japan for the prevention of influenza.
Automation > IT & Software > News
Fibrocell to develop, manufacture genetically-modified cell therapy for RDEB treatment
Fibrocell Science has announced that Progenitor Cell Therapy (PCT), a subsidiary of NeoStem (NBS), has been engaged by Fibrocell’s collaborator, Intrexon Corporation (XON), to provide production capabilities in the generation of cell therapies for the rare disease Recessive Dystrophic Epidermolysis Bullosa (RDEB).
Automation > IT & Software > News
Hemispherx secures US composition of matter patent covering Ampligen formulations
Hemispherx Biopharma has announced that on 13 May 2014, the US Patent Office issued US Patent 8,722,874 titled 'Double-Stranded Ribonucleic Acids with Rugged Physiochemical Structure and Highly Specific Biologic Activity' to inventors Carter, et al. and assignee Hemispherx Biopharma.
Automation > IT & Software > News
RXi Pharmaceuticals granted US notice of allowance covering sd-rxRNA technology platform
RXi Pharmaceuticals has announced that it received the notice of allowance from the US Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
Automation > IT & Software > News
MediWound begins Phase II trial of EscharEx to treat chronic wounds
By PBR Staff Writer
Israel-based biopharmaceutical firm MediWound has started its second Phase II clinical trial of EscharEx for the treatment of chronic and other hard-to-heal wounds.
Automation > IT & Software > News
Parexel launches perceptive MyTrials Data-Driven Monitoring solution
Parexel International, a global biopharmaceutical services organization, has announced the launch of its Perceptive MyTrials Data-Driven Monitoring solution.
Automation > IT & Software > News
Clinverse enters into strategic partnership with eClinical Insights
By PBR Staff Writer
Clinverse, a US-based firm that automates the financial lifecycle of global clinical trials, has entered into a strategic partnership with eClinical Insights, a provider of cloud-based clinical trials software.
Automation > IT & Software > News
AADi, Celgene ink licensing deal for nanotechnology-based drug candidate
By PBR Staff Writer
US-based clinical stage biopharmaceutical firm AADi has entered into an inlicensing agreement with Celgene for ABI-009, a nanoparticle albumin-bound (nab) version of the mTOR inhibitor sirolimus or rapamycin.
Automation > IT & Software > News
Medidata and TransCelerate BioPharma announce joint initiative
Medidata has announced that it is partnering with TransCelerate BioPharma on a project designed to inform the nonprofit organization’s continued efforts to modernize and streamline the way clinical trials are conducted and monitored worldwide.
Automation > IT & Software > News
Takeda, Wipro partners to enable global IT platform
By PBR Staff Writer
Japan-based Takeda Pharmaceutical Company (Takeda) has entered into a partnership with Indian Information Technology, Consulting and Outsourcing firm Wipro to enable a global IT Platform.
Automation > IT & Software > News
Kymab secures $40m investment to advance clinical development of antibody therapeutics
Kymab, a monoclonal antibody biopharmaceutical company, has announced it has successfully raised $40m in a Series B financing.
Automation > IT & Software > News
Horizon Discovery to acquire CombinatoRx service business and assets from Zalicus
Horizon Discovery has agreed to acquire the CombinatoRx service business (known as the combination high throughput screening (cHTS) business) and related assets from Zalicus, a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, for £4.74m ($8.0m).
Automation > IT & Software > News
Ohr Pharmaceutical agrees to acquire technology assets of SKS Ocular
Ohr Pharmaceutical (OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, has entered into a definitive agreement with privately held SKS Ocular and its affiliate SKS Ocular 1 (SKS Ocular) to acquire SKS Ocular's ophthalmology assets.
Automation > IT & Software > News
Novozymes to provide drug-albumin conjugation platform in collaboration with ThioLogics
By PBR Staff Writer
US-based Novozymes Biopharma and UK-based biotechnology firm, ThioLogics, have entered a new collaboration, which brings together Novozymes' modified recombinant human albumin (rAlbumin) Veltis technology, with ThioLogics' site-specific next generation maleimide conjugation platform.
Automation > IT & Software > News
Questcor enters into development agreement for new melanocortin peptides
By PBR Staff Writer
US-based Questcor Pharmaceuticals has entered into a development collaboration agreement with an undisclosed privately held European company for the development of new melanocortin peptides.
Automation > IT & Software > News
91-105 of 1410 results